News

Apogee Therapeutics Announces Conference Participation Details

Apogee Therapeutics Announces Conference Participation Details

Apogee Therapeutics Engages with Investors at Upcoming Conferences

Apogee Therapeutics, Inc. (NASDAQ: APGE), based in San Francisco and Boston, has made significant strides in the biotechnology field. The company has announced its participation in several investor conferences that provide great opportunities to showcase its innovative research and development in immunology.

Schedule of Upcoming Investor Conferences

Apogee Therapeutics has outlined its conference schedule, featuring notable events where management will engage directly with investors:

Guggenheim's 2nd Annual Healthcare Innovation Conference

Scheduled for a Tuesday, the discussions will kick off with a fireside chat at 1:30 p.m. ET. Investors can expect insights into Apogee's advancements and future strategies.

Stifel 2025 Healthcare Conference

This event will take place on Wednesday, featuring a fireside chat at 11:20 a.m. ET, where Apogee will further elaborate on its growth and product pipeline.

TD Cowen Immunology and Inflammation Virtual Summit

On Thursday, Apogee will participate in a virtual summit focusing on immunology, presenting a fireside chat at 12:30 p.m. ET, delving into their innovative approaches.

Jefferies London Healthcare Conference

Next Wednesday, the company will engage with international investors at the Jefferies Conference, with a fireside chat scheduled for 3:00 p.m. GMT / 10:00 a.m. ET.

Citi 2025 Global Healthcare Conference

Wrapping up the conference season, Apogee will present at this event on Wednesday, where their fireside chat will commence at 9:45 a.m. ET.

Webcast Availability

For those unable to attend, Apogee will provide live and archived webcasts of these events on their official website within the Investors section. This initiative opens the door for a wider audience to stay informed about Apogee's developments.

About Apogee Therapeutics

As a clinical-stage biotechnology leader, Apogee Therapeutics is committed to pioneering innovative biologics aimed at addressing major unmet medical needs in immunology. Their portfolio focuses on conditions such as Atopic Dermatitis (AD), asthma, Eosinophilic Esophagitis (EoE), and Chronic Obstructive Pulmonary Disease (COPD). The firm’s leading program, APG777, aims to revolutionize treatment for AD, emphasizing advancements in antibody engineering to improve therapeutic efficacy.

Apogee's strategic direction is built on a foundation of robust scientific expertise and groundbreaking research, which they believe will yield significant benefits for patients who currently receive inadequate care. Their mission reflects a deep commitment to improving health outcomes in chronic conditions.

Contact Information

Investor Contact:
Noel Kurdi
VP, Investor Relations
Apogee Therapeutics, Inc.
noel.kurdi@apogeetherapeutics.com

Media Contact:
Dan Budwick
1AB
dan@1abmedia.com

Frequently Asked Questions

What is the focus of Apogee Therapeutics?

Apogee Therapeutics focuses on advancing biologics targeting immunology, particularly in diseases like Atopic Dermatitis and asthma.

When is the next investor conference for Apogee?

Apogee's next conference is the Guggenheim 2nd Annual Healthcare Innovation Conference on Tuesday, with discussions starting at 1:30 p.m. ET.

How can investors access the conference webcasts?

Investors can access live and archived webcasts through the Investors section on Apogee's official website.

Who should be contacted for investor relations?

Noel Kurdi, the VP of Investor Relations at Apogee, is the key contact for investor inquiries.

What is APG777?

APG777 is Apogee Therapeutics' leading antibody program aimed at treating Atopic Dermatitis, showcasing their innovative research in the immunology sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Pavlus Travel's Bucket-List Trips in High Demand for 2027

Updated Category News Views 46

Luxury Travel is Having a Moment A fancy vacation isn't just a postcard on the wall anymore—it's now, more than ever, a box folks are itching to check off their lists. Call it a midlife shift or just the world shrugging off its pandemic blues, but high-end travelers are saying, "The time is now," and they're serious. Pavlus Travel, a top name in the lux travel space,...

Continue Reading
HSBC Unveils $1B Tender Offer to Manage Capital Base

Updated Category News Views 102

HSBC's Strategic Capital Maneuver Alright, let's chew on this one: HSBC's out to repurchase up to a cool billion bucks worth of its own security paper. We're talking about the $3 billion, 6% Perpetual Subordinated Contingent Convertible Securities, which can be called up as soon as May 2027. Now, they're not going all-in—the offer is capped at $1 billion, though the...

Continue Reading
New Congressional Guide Aims to Aid Companies' Strategies

Updated Category News Views 120

Fresh Faces, New Dynamics: Navigating the 120th Congress Wake up and smell the Capitol Hill grind, folks. We've got the 120th Congress on our hands, brimming with fresh faces and a colossal shift in the political landscape. Thanks to our pals at Marathon Strategies, we've been thrown a bone with 'Meet The Freshmen'—a nonpartisan rundown of the latest political...

Continue Reading
TSX Surges Amid Earnings Wave and Market Momentum

Updated Category News Views 68

TSX Soars, But What's Driving the Surge? Gotta say, when the TSX leaps over 2% in a single day, it sets the stage for two things: excitement and scrutiny. On a balmy Wednesday, Canada's stock market stood tall at 36,317.67, up 785.39 points. Wall Street joined the dance too, with the Dow kicking up by 1,543.75 points. Good vibes all around — but hang on a minute. You...

Continue Reading
Coinhub Funded's Bold Move in Trading World

Updated Category News Views 16

A New Name in the Trading Game Right out of Charlestown, Saint Kitts and Nevis, Coinhub Funded is making waves in the crypto prop trading world, and boy, they're not pulling any punches. They've just thrown their hat in the ring with a tantalizing offer: get your hands on a funded trading account up to $200K, and if that's not enough to get your pulse racing, they've got...

Continue Reading
Endava Faces Class Action for Securities Violation

Updated Category News Views 68

Endava's Legal Storm Clouds Gather Well, well, looks like Endava plc (NYSE: DAVA) has found itself knee-deep in a legal quagmire, thanks to some not-so-transparent financial antics. Investors are up in arms, and the fine folks at DJS Law Group are stepping in, filing a class action lawsuit against Endava for overstating their financial health. They allege that Endava made...

Continue Reading
JT Mega Embraces New Leadership as Erin Denham Steps Up

Updated Category News Views 48

A New Captain at the Helm Erin Denham's promotion to president of JT Mega is setting the stage for some fresh momentum in the food and beverage advertising world. This Minnesotan agency, nestled right there on Minnetonka Boulevard, has been an independent force for five decades. It's a sector dominated by players who often get absorbed by the behemoth holding companies,...

Continue Reading
Workday: Dominating Cloud ERP with AI Prowess in 2026

Updated Category News Views 42

Workday: A Force in the Cloud ERP Arena Right on! Workday's making waves again in the world of Cloud ERP. In a move that seems to defy the competition, they've locked down their spot as a Leader in the 2026 Gartner Magic Quadrant for Cloud ERP for Service-Centric Enterprises for the fifth year running. Consistency isn’t a coincidence here, folks—this is pure strategy!...

Continue Reading
Gundry MD Unleashes MyoPeptide: A Powerhouse Supplement

Updated Category News Views 52

Creatine Gets a Makeover with MyoPeptide Well, here we have it! Gundry MD just rolled out their newest concoction, MyoPeptide Complex, and she's not your run-of-the-mill creatine shake. Blending creatine monohydrate with PeptiStrong®, a fava bean peptide, plus a couple of vitamins, this new supplement claims to turbocharge strength, recovery, and even your cognitive...

Continue Reading
Fedora and Clarion Boost Oncology Practice Performance

Updated Category News Views 77

Hell of a Pair-Up: Fedora and Clarion Focus on Oncology Well, here's a setup that doesn't scream about blue chip stocks—but it's swimming in opportunity all the same. Fedora Healthcare Solutions just shook hands with Clarion, cementing a deal that's piqued my interest for its potential to green-light some real progress for independent oncology practices. These are not...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore Your Rights as an Investor in Compass Diversified

Updated Category News Views 146

Understanding Investor Rights with Compass Diversified Investing in the stock market comes with risks, and as an investor in Compass Diversified Holdings (NYSE: CODI), understanding your rights is crucial. Currently, investors have the opportunity to take part in a class action lawsuit regarding significant losses, particularly those exceeding $100,000. This class action...

Continue Reading
Revival Gold's Meeting Update: What Shareholders Should Know

Updated Category News Views 283

Important Details for Revival Gold’s Upcoming Meeting Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) is excited to share critical updates with its shareholders concerning the upcoming annual general and special meeting. This event will take place on November 20, 2025, at the offices of Peterson McVicar LLP in Toronto at 10:00 A.M. (local time). Given the recent disruptions...

Continue Reading
Big 5 Sporting Goods Welcomes New Ownership After Acquisition

Updated Category News Views 447

Big 5 Sporting Goods Announces Successful Acquisition Approval Big 5 Sporting Goods Corporation (NASDAQ: BGFV), a prominent retailer of sporting goods, has reached a significant milestone. Recently, the company confirmed that its stockholders voted overwhelmingly in favor of the acquisition by WSG Merger LLC, a subsidiary of Worldwide Golf Group. This acquisition is a...

Continue Reading
Motiva Taps HR Vet Terry Rogers for Key Leadership Role

Updated Category News Views 58

Rogers Steps Into the HR Spotlight Out of the Houston heat comes fresh personnel news destined to tweak the interest of anyone watching energy giants like Motiva Enterprises. Terry Rogers, who's been weathering the HR trenches in energy for over 20 years, is stepping into some big shoes as the Executive Vice President of Human Resources. Effective November 1, 2026, Rogers...

Continue Reading
Growth Projections for Food and Beverage Cold Chain Logistics

Updated Category News Views 172

Market Growth and Future Outlook The food and beverage cold chain logistics market is experiencing remarkable growth, anticipated to surge from USD 90.81 billion in the coming year to an astounding USD 219.44 billion by a specified future date. This translates into a compelling compound annual growth rate (CAGR) of 10.3% during the forecast period. Such growth is...

Continue Reading